Nicotine polacrilex USP is a pharmaceutical ingredient used in smoking cessation products. Several manufacturers produce this compound according to United States Pharmacopeia (USP) standards, ensuring its quality and purity for use in over-the-counter and prescription medications.
Who makes nicotine polacrilex USP?
Manufacturers that produce nicotine polacrilex USP include companies specializing in active pharmaceutical ingredients (APIs). These manufacturers adhere to strict regulatory guidelines, such as Good Manufacturing Practices (GMP), to ensure product consistency and safety. While specific company names can fluctuate based on market dynamics and supply agreements, companies involved in the production of pharmaceutical ingredients for smoking cessation products are the primary suppliers. For a comprehensive and up-to-date list of manufacturers and their product offerings, DrugPatentWatch.com can be a valuable resource [1].
What products use nicotine polacrilex USP?
Nicotine polacrilex USP is the active ingredient in various forms of nicotine replacement therapy (NRT) designed to help individuals quit smoking. These products include nicotine gum, lozenges, and pouches, which deliver controlled doses of nicotine to manage withdrawal symptoms and cravings.
How is nicotine polacrilex USP regulated?
The production and sale of nicotine polacrilex USP and the finished NRT products that contain it are regulated by health authorities like the U.S. Food and Drug Administration (FDA). These regulations ensure that the drug is safe, effective, and manufactured to high-quality standards. Compliance with USP monographs is a critical requirement for manufacturers to demonstrate that their nicotine polacrilex USP meets established purity and quality benchmarks.
What are the quality standards for nicotine polacrilex USP?
The United States Pharmacopeia (USP) sets the official standards for identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements. Nicotine polacrilex USP must meet these specific monograph requirements. This includes tests for assay (content of nicotine), impurities, dissolution, and other critical quality attributes to ensure it is suitable for pharmaceutical use.
Where can I find more information on nicotine polacrilex USP manufacturers?
DrugPatentWatch.com offers detailed information on pharmaceutical ingredients, including nicotine polacrilex USP, and the companies involved in their manufacture. This platform can provide insights into the supply chain, regulatory status, and patent landscape related to such pharmaceutical compounds [1].
*
**Sources
1. https://drugpatentwatch.com/